Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories In...

FDA Drug Recall #D-1033-2020 — Class II — March 13, 2020

Recall Summary

Recall Number D-1033-2020
Classification Class II — Moderate risk
Date Initiated March 13, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sun Pharmaceutical Industries, Inc.
Location Cranbury, NJ
Product Type Drugs
Quantity 172,320 bottles

Product Description

Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.

Reason for Recall

CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot #: 3983720, Exp 10/2020; 3990461, 3990464, 3990465, 3990466, 3990470, Exp 11/2020; AA42499, AA42510, AA44468, AA44470, Exp 04/2021; AA55073, AA55074, AA55075, Exp 05/2021; AA61486, Exp 06/2021

Other Recalls from Sun Pharmaceutical Industries, Inc.

Recall # Classification Product Date
D-1032-2020 Class II Doxycycline Capsules, USP, 75 mg, 100-count bot... Mar 13, 2020
D-1047-2020 Class II Atorvastatin Calcium Tablets, USP 40 mg, Rx onl... Mar 9, 2020
D-0788-2020 Class II Testosterone Cypionate for Injection, 2,000 mg/... Jan 14, 2020
D-0787-2020 Class II Testosterone Cypionate for Injection, USP, 1,00... Jan 14, 2020
D-0660-2020 Class II Sumatriptan Succinate Tablets, 100 mg packaged... Dec 26, 2019

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.